Through experimental validation of the hub targets (VEGFA, IL-6, p-STAT3, and p-JAK2), the JAK/STAT signaling pathway was identified as the mechanism of QLQX against inflammatory process in CHF. Here, JAK2 is linked to congestive heart failure.